QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway
ConclusionOur data indicate that upregulation of GLI1 induced by QKI deficiency maintains GSC stemness and enhances the invasiveness of GBM cells, thereby hinting at new options for the treatment of GBM.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Tumor | Cancer & Oncology | Databases & Libraries | Glioma | Neurology | Stem Cell Therapy | Stem Cells | Zinc